SEC Form 4 · accession 0001106578-26-000086
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Jun 25, 2026
Accepted (ET)
Jun 26, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 25, 2026 | M | 9,500 | $135.42 | A | 50,013 | D | |
| Common StockF2 | Jun 25, 2026 | S | 684 | $543.5385 | D | 49,329 | D | |
| Common StockF3 | Jun 25, 2026 | S | 418 | $545.0837 | D | 48,911 | D | |
| Common StockF4 | Jun 25, 2026 | S | 301 | $546.3775 | D | 48,610 | D | |
| Common StockF5 | Jun 25, 2026 | S | 441 | $547.8738 | D | 48,169 | D | |
| Common StockF6 | Jun 25, 2026 | S | 645 | $548.7705 | D | 47,524 | D | |
| Common StockF7 | Jun 25, 2026 | S | 762 | $549.5483 | D | 46,762 | D | |
| Common StockF8 | Jun 25, 2026 | S | 1,617 | $550.8637 | D | 45,145 | D | |
| Common StockF9 | Jun 25, 2026 | S | 1,814 | $551.6068 | D | 43,331 | D | |
| Common StockF10 | Jun 25, 2026 | S | 1,778 | $552.6806 | D | 41,553 | D | |
| Common StockF11 | Jun 25, 2026 | S | 800 | $553.9663 | D | 40,753 | D | |
| Common StockF12 | Jun 25, 2026 | S | 240 | $554.8417 | D | 40,513 | D | |
| Common Stock | holding | — | — | — | 166 | I | by Spouse | |
| Common StockF13 | holding | — | — | — | 324,443 | I | by Trust | |
| Common StockF14 | holding | — | — | — | 249,108 | I | by Trust | |
| Common StockF15 | holding | — | — | — | 45,596 | I | by Trust | |
| Common StockF16 | holding | — | — | — | 8,902 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $135.42 | Jun 25, 2026 | M | 9,500 | D | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 9,500 | 115,718 | D |
| Stock OPtionF17 | $135.42 | holding | — | — | — | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 349,192 | 349,192 | I |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $552.25 to $553.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $553.44 to $554.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $554.46 to $555.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F14Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F15Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F16Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F17Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2This transaction was executed in multiple trades at prices ranging from $543.12 to $543.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $544.65 to $545.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $545.87 to $546.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $547.21 to $548.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $548.21 to $549.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $549.21 to $550.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $550.22 to $551.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $551.23 to $552.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.